Business programme
26.06.2024
16:45–18:15

Legal Regulation of the Introduction of Healthcare Innovations

Congress Centre, conference hall D4
Society and Human Rights
Broadcast
Russia needs to create its own critical technologies or take them to a new level, including the manufacturing of drugs. Developing this key segment is crucial to ensuring the country’s technological sovereignty. In this regard, the issue of regulatory support for innovations related to the healthcare system takes on added importance. One of the main goals in this regard is to increase the efficiency, volume, types, and quality of medical services in line with the needs of the population as well as the advanced achievements being made in medical science. Often, the direct incorporation of new technologies into practice is hampered by the insufficient flexibility of the regulatory system. This leads to difficulties both in terms of the development of and ensuring subsequent access to drugs and, as a result, the significant limitation of patients’ ability to receive modern, high-quality medical care. Issues concerning regulatory support are important for innovations related to digital technologies, additive technologies, biomedical cell products, molecular genetic research, and much more. In this regard, it is crucial to pay attention to and discuss ways to draft legislation on issues related to the development of such medical technologies, as well as approaches to their inclusion in the public funding system and ensuring their effective use. What legal norms are currently limiting factors and which ones will create the conditions needed to develop and introduce innovative technologies in the clinical practice of Russian healthcare? What are the risks of introducing artificial intelligence into healthcare? What financial opportunities exist for artificial intelligence in healthcare? What mechanisms could be proposed to take into account the absence or insufficiency of data needed to adopt a decision on funding? Are doctors and the healthcare system ready to use innovative medical technologies?

Moderator

Anna Solovieva-Oposhnyanskaya
Expert, Institute for National and Comparative Law Studies, Faculty of Law, National Research University Higher School of Economics

Speakers

Albina Gadzhieva
Deputy Dean, Faculty of Law; Director, Institute for National and Comparative Law Research, National Research University Higher School of Economics
Dmitry Galkin
Director of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation (online)
Valentin Dodonov
Director of the Market Access Department, BIOCAD Joint Stock Company
Yulia Ilyinova
Vice Rector for Academic Affairs, Saint-Petersburg State Chemical and Pharmaceutical University
Aleksey Kedrin
Chairman of the Board, Association of Pharmaceutical Manufacturers of the Eurasian Economic Union (EAEU)
Igor Korobko
Head of Science and Innovative Development of Health Department, Ministry of Health of the Russian Federation (online)
Valentina Kosenko
General Director, Scientific Center for Expertise of Medicinal Products of the Ministry of the Ministry of Health of the Russian Federation (online)
Vitaliy Omelyanovskiy
General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Nadezhda Rukavitsyna
Head of the Center for Support of Innovation Implementation, Center for Expertise and Quality Control of Medical Care of the Ministry of Health of the Russian Federation
Vaseliy Ryazhenov
Head of the Department of Regulatory Relations in the Field of Circulation of Medicines and Medical Devices, First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation

Front row participant

Svetlana Solovyova
Assistant to the Minister of Health of the Russian Federation (online)

Broadcast

<